These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1027 related articles for article (PubMed ID: 27376475)

  • 1. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2.
    Schenk D; Song G; Ke Y; Wang Z
    PLoS One; 2017; 12(7):e0181062. PubMed ID: 28704513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.
    Weren RD; Mensenkamp AR; Simons M; Eijkelenboom A; Sie AS; Ouchene H; van Asseldonk M; Gomez-Garcia EB; Blok MJ; de Hullu JA; Nelen MR; Hoischen A; Bulten J; Tops BB; Hoogerbrugge N; Ligtenberg MJ
    Hum Mutat; 2017 Feb; 38(2):226-235. PubMed ID: 27767231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
    Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
    J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing.
    Dacheva D; Dodova R; Popov I; Goranova T; Mitkova A; Mitev V; Kaneva R
    Mol Diagn Ther; 2015 Apr; 19(2):119-30. PubMed ID: 25893891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
    Hernan I; Borràs E; de Sousa Dias M; Gamundi MJ; Mañé B; Llort G; Agúndez JA; Blanca M; Carballo M
    J Mol Diagn; 2012; 14(3):286-93. PubMed ID: 22426013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders.
    Guzel F; Romano M; Keles E; Piskin D; Ozen S; Poyrazoglu H; Kasapcopur O; Demirkaya E
    Front Immunol; 2021; 12():666273. PubMed ID: 34177904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.
    D'Argenio V; Esposito MV; Telese A; Precone V; Starnone F; Nunziato M; Cantiello P; Iorio M; Evangelista E; D'Aiuto M; Calabrese A; Frisso G; D'Aiuto G; Salvatore F
    Clin Chim Acta; 2015 Jun; 446():221-5. PubMed ID: 25896959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
    Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
    BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of false positive mutations in BRCA gene by next generation sequencing.
    Suryavanshi M; Kumar D; Panigrahi MK; Chowdhary M; Mehta A
    Fam Cancer; 2017 Jul; 16(3):311-317. PubMed ID: 27848044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
    Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
    J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing.
    Han E; Yoo J; Chae H; Lee S; Kim DH; Kim KJ; Kim Y; Kim M
    Clin Chim Acta; 2020 Jun; 505():49-54. PubMed ID: 32092317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
    Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
    J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.
    Costa JL; Sousa S; Justino A; Kay T; Fernandes S; Cirnes L; Schmitt F; Machado JC
    Hum Mutat; 2013 Apr; 34(4):629-35. PubMed ID: 23315985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.